Coronis
Delivering End-to-End CRO Services

Over the years, several kinds of health research have led to significant discoveries, the development of new therapies, and a remarkable improvement in the overall health care of patients. It provides crucial information about disease trends and risk factors, outcomes of treatment or public health interventions, functional abilities, patterns of care, and health care costs and use. As the entire process of health research entails many processes, which needs careful and accurate considerations, a large number of pharmaceutical, biotechnology, and medical device companies employ contract research organisations (CROs) that lend supporting hands in their health research endeavour. However, oftentimes, the CROs do not offer end-to-end support services throughout the development stages that hinder the drug development process to a large extent.

This is where Coronis comes to the picture that delivers a full spectrum of tailor-made services along with the highest quality standards to national and international pharmaceutical, biotechnology and medical device companies and other healthcare-related organisations. With its clinical research and commercialisation capabilities, most advanced science, business and data technologies, the company guarantees a product’s successful entry into the market, ensuring the flawless design and perfect coordination at all development stages.

The company bases its regulatory and clinical research strategy upon its code of ethics and the clients’ needs, enabling it to successfully collaborate with pharma and biotech companies in their phase I-IV and medical device development programs. Whether it is end-to-end project execution or an on-demand specific project, Coronis offers the highest level of clinical development services by delivering the project on time without burning a hole in the clients’ pockets.

Additionally, the company also delivers real-world data that helps clients understand their products’ real value in the market. The data enables them to understand the long-term safety and tolerance of the product, patients’ experience along with the pros and cons of the product. This enables clients to design the path of successive procedures.

Moreover, once the product is ready, the market experts at Coronis help the clients introduce their product in the local market, find its proper commercial position and communicate its value to potential customers and key healthcare professionals (HCPs). Besides, after the product’s launch to the market, the company provides continuous support throughout the product’s lifecycle, helping the clients to improve its market performance and increase brand equity. Further, as patients’ safety and well-being are paramount for the product’s safety profile and overall effectiveness, the company provides Vigilance services to respond exceptionally, even to the highest demands. In full compliance with the National and European Legislation on medicinal products, medical devices and cosmetics, Coronis’ pharmcovigilance experts provide around the clock excellent consultation services while giving clients great insight into their vigilance strategy planning.

More importantly, the company renders a full range of regulatory affairs activities for prescription medicines, essential similar products, OTCs, food supplements, and others. It offers support across all phases of the clinical development project, from the start-up activities of a clinical trial to the product registration and marketing authorisation application. Not only this, the company also has a robust training and learning program that begins upon the hiring of a new employee and continues throughout that employee’s tenure with the organization.

Established in 1997, the company has been climbing the ladder of success by helping its clients accomplish their drug development and market access objectives successfully. Coronis is awarded with ISO 9001:2015 Quality Certification, across all company’s divisions and functions, and is approved by the Greek Competent Authority as a CRO. Also, being one of the founding members of HACRO (Hellenic Association of CROs) and an active member of EUCROF (European CRO Federation), the company is at the forefront of changes and improvements in the CRO industry. Going forward, the company plans to add more innovations to its offerings to become the most valuable and reliable partner for its clients across the whole product’s life cycle.